title: Hyperglycemia following intralesional corticosteroid injection in a patient with type I diabetes mellitus.
abstract: METHODS
  A 36-year-old woman with well-controlled type 1 diabetes mellitus reported hyperglycemia (plasma glucose peaked at 21.3 mmol/L) after her first injection with intralesional triamcinolone acetonide for alopecia areata.
  
  
  CONCLUSIONS
  Intralesional corticosteroids are used to maximize local effect while presumably minimizing systemic complications. This adverse effect is an important consideration when treating patients with insulin-dependent diabetes mellitus, and it would be reasonable to counsel patients of such a possibility.
authors.forename: Patrick
authors.initials: P
authors.lastname: Fleming
authors.forename: Leah
authors.initials: L
authors.lastname: Drazek
authors.forename: James C
authors.initials: JC
authors.lastname: Shaw
mesh_terms: D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D015552:Injections, Intralesional; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide